Cabaletta Bio Inc
CABA
NASDAQ
Biotechnology
$2.75
USD
+0.04 (+1.48%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $442.69M
Volume 2.3M
Revenue
$0
TTM
— YoY
Gross Margin
—
TTM
— YoY
Net Income
$-175.43M
TTM
-38.4%
YoY
Operating Cash Flow
$-142.84M
TTM
-50.3%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 |
|---|---|---|---|---|---|
Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
YoY Growth | — | — | — | — | — |
Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross Profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Selling, General & Administrative | 8.1 | 8.3 | 6.8 | 6.4 | 6.9 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | -0.3 |
Total Operating Expenses | 37.1 | 45.9 | 46.6 | 42.6 | 44.0 |
Operating Income | -37.1 | -45.9 | -46.6 | -42.6 | -44.0 |
EBITDA | -36.7 | -45.4 | -46.2 | -42.3 | -43.6 |
Other Income / Expense | 0.0 | -0.1 | 0.5 | -0.1 | 0.0 |
Total Other Income / Expense | 1.2 | 0.8 | 1.7 | 0.7 | 0.4 |
Income Before Income Taxes | -35.9 | -45.1 | -44.9 | -41.9 | -43.5 |
Income Taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net Income | -35.9 | -45.1 | -44.9 | -41.9 | -43.5 |
Consolidated Net Income / Loss | -35.9 | -45.1 | -44.9 | -41.9 | -43.5 |
Net Income Attributable to Common Shareholders | -35.9 | -45.1 | -44.9 | -41.9 | -43.5 |
Basic EPS | -$0.71 | -$0.73 | -$0.44 | -$0.40 | -$0.39 |
Diluted EPS | -$0.71 | -$0.73 | -$0.44 | -$0.40 | -$0.39 |
Basic Shares Outstanding | 50.7M | 61.9M | 102.3M | 104.7M | 112.0M |
Diluted Shares Outstanding | 50.7M | 61.9M | 102.3M | 104.7M | 112.0M |